Human Metabolome Technologies, Inc.
Notice regarding the status and completion of treasury stock acquisitions
From August 1, 2026 to August 26, 2026, 42,200 shares of common stock were acquired through market purchases, totaling 25,686,800 yen. This transaction is part of the previously announced plan approved by the board on February 12, 2026 to acquire up to 250,000 shares (4.4%), with an acquisition period from February 13, 2026 to December 31, 2026; the company has announced that the acquisition has now ended.
Key Figures
- Total number of shares acquired: 42,200 shares
- Total amount of shares acquired: 25,686,800 yen
- Cap on shares: 250,000 shares (4.4%)
AI要約
Overview of treasury stock acquisitions
This notice reports the status and completion of treasury stock acquisitions pursuant to the provisions of Article 165, Paragraph 2 and Article 156 of the Companies Act. This time, 42,200 shares of common stock were acquired through market purchases, for a total amount of 25,686,800 yen. The acquisition period was set from August 1 to August 26 (on an execution basis), and the transactions were conducted as part of the purposes decided by the Board of Directors.
Background and outlook
In the February 12, 2026 board resolution, the total number of treasury stock to be acquired was capped at 250,000 shares (4.4% of issued shares, up to 200 million yen). The acquisition period was set from February 13, 2026 to December 31, 2026. This notice also announces that acquisitions under that resolution have ended. The impact on future capital policy and dilution control are not described in this公告.
Human Metabolome Technologies, Inc.
Company overview · Stock price · Financial data · All IR
